GENERAL INFORMATION FOLLOWED BY A TENTATIVE STATEMENT OF WORK NOTICE: This is not a solicitation but rather a Request for Information (RFI) (Sources Sought) to determine capability of potential sources and is for information and planning purposes only. Veterans Health Affairs, Network Contracting Office 4, is issuing this request for information/sources sought notice in order to identify capable small business firms to perform services for the VA Pittsburgh Healthcare System (VAPHS) located at University Drive C, Pittsburgh, PA 15240. Responses must be submitted by 2:00 PM (EST) April 7, 2017. Submit responses to the information requested above via email to [email protected] . All SDVOSB and VOSB firms that respond shall include proof of CVE certification via www.vip.vetbiz.gov. All small business firms that respond shall include proof of small business status via their Representations and Certifications in accordance with (FAR 4.1102 Policy). While SDVOSB/VOSB contractors are preferred, all capable contractors are welcome to respond to this sources sought notice for market research purposes, and shall include as part of their response a brief capability statement that covers the information in the following tentative statement of work The results of this market research will assist in the development of (1) the requirement, and (2) the acquisition strategy (e.g., socioeconomic set-aside, full and open competition, etc.). VA assumes no responsibility for any costs incurred associated with the preparation of responses. SAMPLE STATEMENT OF WORK FOR ANATOMIC PATHOLOGY REFERENCE LABORATORY TESTING AT VA Pittsburgh Healthcare System (VAPHS) located at University Drive C, Pittsburgh, PA 15240 Contractor shall provide all employees, supervision, supplies and equipment necessary to perform specialized services for Anatomic Pathology specimens to include Immunohistochemistry Stains, Cytochemical Stains, Flow Cytometry, FISH testing, Cancer Marker Testing and other esoteric testing for the VA Pittsburgh Healthcare System (VAPHS) located at University Drive C, Pittsburgh, PA 15240. The VAPHS will package specimens according to the guidelines required by the contractor. Contractor shall provide all necessary supplies for biomedical materials to be transported from the VAPHS Medical Center, Laboratory to the Contractor s laboratory. These supplies shall include, but may not be limited to: Shipping and packaging containers. Packing material must be capable of maintaining temperature requirements for specimens until they reach the Contractor s laboratory. Required labels and packaging materials for shipping specimens via courier that are infectious, or etiologic agents, in accordance with appropriate requirements of 49 CFR Part 72, CFR Parts 171 and 173, and the Dangerous Goods Regulations of the International Air Transport Association (IATA) consistent with current regulatory updates. Contractor must ensure the security of the specimen contains and protect against the accessibility of the specimens and the information that accompanies the specimens. Routine transportation services shall occur once per day, Monday Friday, except for Federal Holidays. Specimen pick-up times will be late afternoon between 5PM 7PM. Vendor may transport specimens by courier or via FED-X/ UPS. If using FED-X or UPS, the vendor will supply pre-paid envelopes for shipping specimens. Pick-up of specimens will be from the Processing Dept., currently located on 2nd Floor, room 2NW101. All Blocks and prepared slides will be returned to the located at University Drive C, Pittsburgh, PA 15240, Attention: Pathology & Laboratory Medicine via courier drop-off or UPS or FEDX. These materials shall be returned within 7 days after completion of diagnostic studies. Contractor must provide a phone number for consultation Pathology services regarding test results. Services will be minimally Monday through Friday, excluding Federal Holidays, 9AM 5PM. Contractor test reports must contain the following information at a minimum: Patient s full name Patient s identification number (e.g. social security number/ DOB) Physician s name VA Surgical Pathology accession number Submitting Laboratory Name Submitting facility account number Patient s location (clinic/ ward) Tests(s) ordered Date/ time of specimen collection Date/ time test completed Test result Reference intervals (if applicable adjusted for age, sex or race) Interpretation of Results if applicable Name and address of testing laboratory Any other information the laboratory has that may indicate a questionable validity of test results Specimen inadequacy shall be reported with documentation supporting its unsuitability for testing. Hard copy reports should be sent via secure connection. Whenever possible, it is preferred that results are transmitted through an interfaced connection. An on-line account for the Pathologists should also be made available to access results via lab s website. Results will be available within the listed turnaround times. Turnaround time will be from the time the specimen leaves the VHAPTH Laboratory Test Name Turnaround Time Immunohistochemistry Stains 1-2 Days Flow Cytometry 2 Days Morphology 3-4 Days FISH 6 Days Cytogenetics 8 Days Molecular 8 Days The Contractor shall provide the name(s) and telephone number(s) of contractor employees who will address the following customer services throughout the contract performance period: Routine questions and clarifications regarding collection requirements Inquiries regarding the status of pending orders Result interpretation inquires/ Consultative services Inquiries regarding supplies Contractor shall be reimbursed per technical component, professional component or Global component, of the applicable CPT code, depending on the services rendered. CPT codes will include with the projected annual volumes of each: Description/Part Number* CPT Qty ALK by FISH 88271x2; 88274 1 APL(PML-RARA) QUANT 81315 5 B-CELL GENE REARRANGEMENT, PCR 81261 7 BCL 1 GENE REARRANGEMENT N/A 1 BCL-2 GENE REARRANGEMENT N/A 1 BCR-ABL1, CML/ALL, PCR, QUANT 81206; 81207 1 CALR MUTATION ANALYSIS 81219 1 CEBPA MUTATION ANALYSIS 81218 5 CHROMOSOME ANALYSIS, BM 88237; 88264 81 CHROMOSOME, LEUKEMIC BLOOD 88237; 88264 2 C-KIT MUTATION, LIQUID TUMOR 81272 6 Consult EGL Slides 88323 1 EGFR FISH 88271(x2); 88274 1 EGFR Mutation Analysis 81235 1 EGFR Mutations 81235; 88381 1 Factor II, DNA Analysis N/A 1 Factor V Leiden Mutation N/A 1 FISH ANALYZE 100-300 CELLS X1 88275 2 FISH ANALYZE 100-300 CELLS X2 88275 2 FISH ANALYZE 100-300 CELLS X3 88275 26 FISH ANALYZE 100-300 CELLS X4 88275 21 FISH ANALYZE 100-300 CELLS X5 88275 7 FISH ANALYZE 100-300 CELLS X6 88275 23 FISH ANALYZE 100-300 CELLS X7 88275 20 FISH ANALYZE 100-300 CELLS X9 88275 1 FISH ANALYZE 25-99 CELLS X10 88275 1 FISH ANALYZE 25-99 CELLS X5 88275 1 FISH DNA PROBE X1 88271 13 FISH DNA PROBE X10 88271 31 FISH DNA PROBE X2 88271 1 FISH DNA PROBE X3 88271 3 FISH DNA PROBE X4 88271 18 FISH DNA PROBE X5 88271 2 FISH DNA PROBE X6 88271 26 FISH DNA PROBE X7 88271 4 FISH DNA PROBE X8 88271 4 FISH DNA PROBE X9 88271 16 FLOW COMPREHENSIVE SCREENING 88184; 88185x23; 88189 1 FLOW CYTOMETRY, EA ADD MARKER 88185 13 FLOW CYTOMETRY, EA ADD MARKER 88185 12 FLOW CYTOMETRY, EA ADD MARKER 88185 12 FLOW CYTOMETRY, EA ADD MARKER 88185 12 FLOW CYTOMETRY, EA ADD MARKER 88185 12 FLOW CYTOMETRY, EA ADD MARKER 88185 10 FLOW CYTOMETRY, EA ADD MARKER 88185 3 FLOW PLASMA CELL 88184; 88185x16; 88189 1 FLOW TISSUE/FLUID 88184; 88185x18; 88189 5 FLOW TISSUE/FLUID 8 COLOR 88184; 88185x23; 88189 25 FLOW ZAP70 EXPRESSION 88184; 88185(x3); 88187 1 FLT3 INTER.TANDEM DUP(ITD) PCR 81245;81246 9 HANDLING/CONVEYANCE OF SPEC 99001 14 HER2 by FISH 88377 1 HER2 IHC 88360 1 IDH1 and IDH2 Mutation Exon 4 N/A 1 IGK GENE REARRANGEMENT, PCR 81264 4 IGVH MUTATION ANALYSIS 81263 5 IHC 1ST ANTIBODY - TECH ONLY 88342-TC 14 IHC 1ST TECH-PP 88341-Interpretation 2 IHC EA ADDL SINGLE - TECH PP 88341 3 IHC EACH ADDTL AB - TECH ONLY 88341 9 IHC EACH ADDTL AB - TECH ONLY 88341 4 IHC EACH ADDTL AB - TECH ONLY 88341 2 IHC EACH ADDTL AB - TECH ONLY 88341 2 IHC EACH ADDTL AB - TECH ONLY 88341 1 IHC EACH ADDTL AB - TECH ONLY 88341 1 IHC Multiplex x1 Tech 88344 1 IHC Prog/Pred TS/EGFR/p27/p53 88360 1 IHC TUMOR TECH COMPONENT ONLY 88360 15 IntelliGEN (SM) 81445; 88381 1 ISH 1st Probe 88365 1 ISH Addtl Probe 88364 1 JAK2 EXON 12 MUTATION ANALYSIS 81403 2 JAK2 V617F MUTATION DETECTION 81270 3 KIT (D816V) MUTATION, PCR FL N/A 1 KRAS Mutation Analysis 81275 1 KRAS Mutation Analysis, CRC 81275 1 Microdissection Global 88381 1 Microsatellite Instability 81301; 88381 1 MM ENRICH CMA N/A 1 Morp Ana, Tumor IHC Manual 88360 1 MPL MUTATION ANALYSIS 81402 1 MYD88 L265P Mutation Detection PCR N/A 1 MYD88 Mutation Detection PCR 81479 1 Myeloid Malignancies Mut NGS N/A 1 NPM1 MUTATION ANALYSIS 81310 6 P53 MUTATION ANALYSIS 81404 3 PDGFRA Analysis in GIST N/A 1 PD-L1 BY IHC (KEYTRUDA (R)) 88342 1 REVEAL (R) SNP CMA - ONCOLOGY 81406 4 ROS1 Oncology FISH 88271x2; 88275 1 Special Stains Group II TC 88313-TC 1 T-CELL GENE REARRANGEMENT, PCR 81340;81342 4 TCRB GENE CLONALITY N/A 1 Quality Assurance Monitoring Contractor must have and maintain licensure and certifications required to operate its laboratory. Monitoring of contractor s performance shall be demonstrated through clinical and administrative record reviews. Services will be monitored through one or a combination of the following mechanisms: Surgical Pathology/ Cytology Department will monitor Contractor performance to ensure that services called for in the contract have been received by VA in a timely manner. Services such as: Specimen pick-up is minimally daily and not earlier than 5PM. Compliance rate for this is minimally 90%. Turn-around times for resulting of tests are at a minimal compliance rate of 90%. Documentation of services performed will be reviewed prior to certifying payment. VA will pay only for services actually provided, and in accordance with the pricing schedule. Quality Factors that will be monitored. PERFORMANCE OBJECTIVE TASKS: PERFORMACE STANDARD ACCEPTABLE (MINIMAL) QUALITY LEVEL MONITORING METHOD Ensure the safety and integrity of specimens No loss or destruction of specimens 100% of the time Contractor reporting; Government inquiries Testing services will be performed in accordance with the defined turnaround times (TAT) Results will be reported within the TAT as stated in the contract 90% of the time 10% of randomly selected tests Pick-up times for specimens are within the designated times +/- 30 min Contractor pick-up specimens with the designated time +/- 30 min 90% of the time Direct Observation

Bid Protests Not Available